Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, will receive the Chairman’s Healthcare Award by the Latin Business Association (LBA) at the 40th Annual Sol Business Awards Gala on Friday, October 14 at the Crowne Plaza Hotel in Los Angeles.
Mannatech was nominated and was unanimously approved for the award by the LBA’s Board of Directors. Annually awarded to a company who is progressively making a difference in the healthcare industry, this recognition was given to Mannatech this year due to the company’s commitment and innovative approach to health and wellness,* as well as its dedication to the Latino community.
“We are honored to be recognized among such a prestigious group of organizations who share in our passion, not only of better health and wellness, but also for the Latino market,” said Alfredo “Al” Bala, Mannatech’s CEO and President. “Mannatech is truly grateful to accept this celebrated award, and we look forward to furthering our devotion to supporting the health and wellness needs of the members of the Latino community.”*
As a part of the company’s commitment to supporting the growing needs of the Latino market, Mannatech will be attending the LBA’s Global Business Summit, which will provide Latinos around the world the possibility to learn more about the company’s business opportunity. With more than 30,000 attendees expected at the event, Mannatech will also share about its unique, glyconutrient-based health, wellness, fitness and skincare products to this group of entrepreneurs, business leaders, government representatives and industry experts from across the U.S. and internationally.
The LBA Global Business Summit will take place October 12-14 at the Crowne Plaza Hotel at Commerce, 6121 Telegraph Road, Commerce, California 90040. Connect with Mannatech and learn more at booth #2829.
To begin transforming your life or the lives of those around you, please visit Mannatech.com.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Mannatech, Incorporated, offers a profound wellness experience through a financially rewarding opportunity that makes a difference in the lives of people across the world. Through its innovative glyconutrition products, Mannatech transforms lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in more than 25 countries, Mannatech is committed to transforming lives. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161010005079/en/Business Wire
Last updated on: 10/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.